483
Frontage Clinical Services, Inc.FDA 483 - Frontage Clinical Services, Inc. - May 20, 2014
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Frontage Clinical Services, Inc. in Hackensack, NJ, a bioavailability/bioequivalency clinical investigator, revealed one significant observation. The firm failed to retain reserve samples of test articles used in a bioavailability study. This indicates a lapse in proper sample retention procedures for clinical research.
Open in Dashboard
ID · 5f3e1f77-8b40-41a8-9ad6-4bb43bd079d9